SCHEMBL30532154

SCHEMBL30532154

Cn1c(=O)[nH]c2ccc(-c3ccc(CO)s3)nc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ GRIN1 Q05586 3/20 0.38
▸ GRIN2B Q13224 3/20 0.38
▸ PDE3B Q13370 4/20 0.37
▸ PDE3A Q14432 4/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ P2RY12 Q9H244 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ PABPC1 P11940 1/20 0.35
▸ CYP2A6 P11509 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30176757 0.79 GRIN1 (0.56) GRIN1GRIN2BMEN1KMT2ALMNA
SCHEMBL30532165 0.78 GAA (0.46) KDM4EGAAGRIN1GRIN2BPDE3B
SCHEMBL11223721 0.70 KDM4E (0.51) KDM4EGAAPDE3BPDE3AMEN1
SCHEMBL5329685 0.70 KDM4E (0.58) KDM4EGAAPDE3BPDE3AMEN1
SCHEMBL31217710 0.70 KDM4E (0.58) KDM4EGAAPDE3BPDE3AMEN1
SCHEMBL31397306 0.68 KDM4E (0.44) KDM4EGAAGRIN1GRIN2BPDE3B
SCHEMBL2268013 0.68 KDM4E (0.59) KDM4EGAAPDE3BPDE3AMEN1
SCHEMBL29636037 0.67 GRIN2B (0.54) GRIN1GRIN2BMEN1KMT2ALMNA
SCHEMBL14609834 0.67 KDM4E (0.58) KDM4EGAAPDE3BPDE3AMEN1
SCHEMBL31397203 0.66 PDE3B (0.47) KDM4EGAAPDE3BPDE3AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3523311-B1 SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-06-07 — — EP disclosed
Send feedback